Outcome or subgroup title,No. of studies,No. of participants,Statistical method,Effect size,comparison_name,comparison_id,effect_size,lower_ci,upper_ci,outcome_id,subgroup_id,outcome_name,subgroup_name
1.1 Pain assessed with visual analogue scale (VAS) during the administration of selected drugs (neonates from 0 to 4 weeks) Show forest plot,2,133,"Mean Difference (IV, Fixed, 95% CI)","0.00 [‐0.23, 0.23]",Continuous infusion versus bolus administration,1,0.0,-0.23,0.23,1,1,,Pain assessed with visual analogue scale (VAS) during the administration of selected drugs (neonates from 0 to 4 weeks) Show forest plot
1.2 Pain assessed with COMFORT scale during the administration of selected drugs (neonates from 0 to 4 weeks) Show forest plot,2,133,"Mean Difference (IV, Fixed, 95% CI)","‐0.07 [‐0.89, 0.75]",Continuous infusion versus bolus administration,1,-0.07,-0.89,0.75,1,2,,Pain assessed with COMFORT scale during the administration of selected drugs (neonates from 0 to 4 weeks) Show forest plot
1.3 Hypotension requiring medical therapy Show forest plot,1,,"Risk Difference (IV, Fixed, 95% CI)",Totals not selected,Continuous infusion versus bolus administration,1,,,,1,3,,Hypotension requiring medical therapy Show forest plot
1.4 Mechanical ventilation longer than 24 hours Show forest plot,3,147,"Risk Ratio (IV, Fixed, 95% CI)","1.62 [1.19, 2.21]",Continuous infusion versus bolus administration,1,1.62,1.19,2.21,1,4,,Mechanical ventilation longer than 24 hours Show forest plot
1.4.1 Morphine,2,131,"Risk Ratio (IV, Fixed, 95% CI)","1.63 [1.20, 2.22]",Continuous infusion versus bolus administration,1,1.63,1.2,2.22,1,4,,Morphine
1.4.2 Fentanyl,1,16,"Risk Ratio (IV, Fixed, 95% CI)","1.29 [0.10, 17.14]",Continuous infusion versus bolus administration,1,1.29,0.1,17.14,1,4,,Fentanyl
